+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Heterozygous familial hypercholesterolemia and cardiovascular risk: a description of French patients
Home
Publications
Heterozygous familial hypercholesterolemia and cardiovascular risk: a description of French patients
Back Home
Heterozygous familial hypercholesterolemia and cardiovascular risk: a description of French patients
2015 11th Congress of Nouvelle Société Francophone d’Athérosclérose (NSFA)
Béliard, S | Millier, A. | Briquet, B. | Carreau, V. | Bruckert, E. |
Volume: , Issue: , Pages: ,
R,
The website uses cookies.
Learn More
Ok
